Skip to content

Breakthrough Therapies for Skin Diseases™

Alphyn Doses First Patient in Phase 2b Clinical Trial of Zabalafin Hydrogel for Atopic Dermatitis

Alphyn
Breakthrough Therapies for Skin Diseases
Alphyn
  • About
    • What We Do
    • Leadership & Board
    • Science Advisory
  • Platform
    • Zabalafin Platform
  • Pipeline
    • Atopic Dermatitis
    • Epidermolysis Bullosa
  • News
    • Press Releases
    • In the News
    • Clinical Presentations
    • Events
  • Contact Us
  • About
    • What We Do
    • Leadership & Board
    • Science Advisory
  • Platform
    • Zabalafin Platform
  • Pipeline
    • Atopic Dermatitis
    • Epidermolysis Bullosa
  • News
    • Press Releases
    • In the News
    • Clinical Presentations
    • Events
  • Contact Us

Daily Archives: July 26, 2023

You are here:
  1. Home
  2. 2023
  3. July
  4. 26

Clinical Trials Arena: Alphyn prepares for two global trials in atopic dermatitis

NewsBy adminJuly 26, 2023

Clinical Trials Arena: Alphyn prepares for two global trials in atopic dermatitis by Urtė Fultinavičiūtė NEWS PROVIDED BY Alphyn Biologics July 26, 2023 Alphyn is planning to open sites in the US, Canada, Europe and Australia. Read the Clinical Trials Arena article here. CONTACTS   Corporate: Neal Koller [email protected] (410) 690-8687   Media: Susan Thomas…

Copyright 2025, Alphyn Biologics, Inc. All rights reserved. | Website Design by ABWeb Beacon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to Top